Literature DB >> 2719015

Cimetidine-induced galactorrhea.

M N Ehrinpreis1, R Dhar, A Narula.   

Abstract

Various breast abnormalities have been described in patients treated chronically with cimetidine, but galactorrhea has been reported only twice in the medical literature. In both cases, there appeared to be an associated hyperprolactinemia. These problems could well represent a consequence of histamine2-receptor blockade. We report here a female patient with hepatic cirrhosis and portal hypertension who developed hyperprolactinemia and galactorrhea while on long-term cimetidine therapy. Both the hyperprolactinemia and the galactorrhea disappeared when the patient was switched to ranitidine, an alternative H2-receptor blocker. A review of the previous case reports and relevant literature is included.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719015

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 2.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 3.  Lobular carcinoma of the male breast associated with the use of cimetidine.

Authors:  P San Miguel; M Sancho; J L Enriquez; J Fernandez; F Gonzalez-Palacios
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

4.  Ranitidine-induced galactorrhea in a postmenopausal female.

Authors:  Prabhat Agrawal; Nikhil Pursnani; Awantika Parihar; Boentika Singh
Journal:  J Family Med Prim Care       Date:  2019-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.